However, Zhang et al. reported that high PCSK9 expression levels in hepatocellular carcinoma are an indicator of poor prognosis, and FASN-mediated anti-apoptotic effects play an important role in PCSK9‐induced hepatocellular carcinoma progression [6]. Here, PCSK9 is linked to hepatocellular carcinoma.